: High-momentum stocks with specific clinical catalysts include ImmunityBio (IBRX) and Erasca (ERAS) .
: A top defensive choice combining retail stability with e-commerce upside; it has 53 years of consecutive dividend increases. available stocks to buy
: Remains a primary AI play; despite high demand, it recently traded at a relatively modest forward P/E of 25. despite high demand
For a more conservative approach, Forbes recommends filtering for stocks with low debt-to-equity and consistent dividend growth. available stocks to buy
: A premium defensive stock with a 69-year track record of dividend growth.